Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

FGFR2b – fibroblast growth factor receptor 2b – is an emerging biomarker that is particularly prominent in gastric cancer and gastroesophageal junction (GEJ) cancer, occurring in around 38% of ...